SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Genta, Inc. (GNTA)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1870 44 0 GNTA
Emcee:  John Nobrega Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1395Genta Launches Follow-up Studies of Genasense(TM) Combination Therapy for Prostabob zagorin-7/11/2000
1394 Good post Cheryl and right on the money, I believe. Re the earlier question on Graham Marshman-6/15/2000
1393 thamnks cheryl, excellent post and not-long winded IMHO. BTW, i think you wouldbob zagorin-6/14/2000
1392 John, Good clear questions! Thanks for persisting. If we amateurs all keep at tCheryl Galt-6/14/2000
1391 "immune deficient" mice...'cuz that would indicate what completelScrapps-6/14/2000
1390 i don't think so. read the book "The Transformed Cell" by Dr. Stebob zagorin-6/14/2000
1389 from your yahoo news release: "Recently, several groups have claimed that John William Anderson-6/14/2000
1388 again, not being a doctor or scientist, i may be getting in over my head here bbob zagorin-6/12/2000
1387 Bob: This news release does indicate that genasense is entering the cells and billkirn-6/12/2000
1386 not a doctor either. there have been problems with inserting genes into humans bob zagorin-6/12/2000
1385 I have been a shareholder in Genta for several years now. My current position tommtn-6/12/2000
1384 GNTA added to Russell Indexes.(Preliminary Russell 3000© Index additions PL Wilson-6/10/2000
1383 Nothing like Worrell to throw cold water on a nice run-up by saying our "Fbvortex-6/9/2000
1382 Research success boosts Genta By Ted Griffith, CBS MarketWatch.com Last Updatbob zagorin-6/8/2000
1381 Not sure how they do these things...<i>"in <b>immune-deficientScrapps-6/7/2000
1380 i just finished reading a book called the "The Transformed Cell" by tbob zagorin-6/7/2000
1379 <i>"In immune-deficient mice transplanted with human lymphoma, treatScrapps-6/7/2000
1378 Genta's antisense could be routinely (eventually)given with chemotherapy anart slott-6/7/2000
1377 Genta's Lead Antisense Drug Boosts Lymphoma Chemotherapy; Investigators Repbob zagorin-6/7/2000
1376 Genta and Molecular Biosystems Announce Licensing Deal For Key Antisense Technobob zagorin-6/5/2000
1375 <i>"Raymond Warrell, CEO of Genta (Nasdaq: GNTA - news), states: ``WScrapps-5/31/2000
1374 see below, excerpt of interview with GNTA CEO in new biotech issue of WST. Thebob zagorin-5/31/2000
1373 they've reduced their burn rate significantly and they do have some cash cobob zagorin-5/25/2000
1372 Bob, I'll use the same quote, you just listed to "prove" my poinLarry Dreher-5/25/2000
1371 Thanks Bob,you beat me to it.Same concern for years.GNTA will survive these triPL Wilson-5/24/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News